Skip to main content
    O

    Oric Pharmaceuticals Inc (ORIC)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $8.00
    +0.48 (+6.38%)

    Market Cap: $779.47M

    Last updated: Nov 17, 2026 at 4:40 PM ET

    Oric Pharmaceuticals Inc (ORIC) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Oric Pharmaceuticals (ORIC) has a market cap of $779.47M and an enterprise value of $745.62M. Revenue fell 100.00% over the last 12 months from the 12 months before. Its share count is up 9.32% from a year earlier.

    Total Valuation

    Enterprise value is 4.34% below the market cap, as cash exceeds debt.

    Market Cap$779.47M
    Enterprise Value$745.62M
    Latest price (Nov 17, 2026)$8.00

    Key Dates

    The next earnings report is expected on Feb 22, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 22, 2027 (expected)
    Last Earnings DateNov 16, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.15% in the quarter ended Sep 30, 2026 and grew 23.84% a year over 2 years.

    Shares Outstanding108.18M
    Shares Change (YoY)+9.32%
    Shares Change (QoQ)+0.15%
    Share Count Growth (2Y CAGR)+23.84%

    Price Statistics

    The stock is down 34.69% over 52 weeks and trades 29.58% below its 50-day average.

    Beta (1Y)1.21
    52-Week Change-34.69%
    1-Month Change-37.11%
    3-Month Change-45.39%
    6-Month Change+0.38%
    5-Year Change-36.89%
    Total Return (1Y)-34.69%
    Total Return (3Y CAGR)+5.36%
    Total Return (5Y CAGR)-13.58%
    Return vs SPY (1Y)-44.33%
    Max Drawdown (1Y)-48.67%
    Max Drawdown (3Y)-73.46%
    Sharpe Ratio (1Y)-0.41
    Correlation with SPY (1Y)0.17
    50-Day Average$11.36
    200-Day Average$10.97
    52-Week Range$7.23 to $14.68
    RSI (14 Days)34.9
    Average Volume (20 Days)1.98M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 11.09x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio11.09x
    Quick Ratio11.09x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -45.90% over the last 12 months, against a 5-year average of -40.02%.

    Return on Equity (ROE)-45.90%
    Return on Assets (ROA)-42.48%
    ROE (5Y Average)-40.02%
    ROA (5Y Average)-36.13%
    ROIC (5Y Average)-29.39%

    Scores

    ORIC has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Gross Profit-$320.00K
    Operating Income-$171.02M
    Pretax Income-$155.84M
    Net Income-$155.84M
    Reported EPS (TTM)-$1.46

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 92.53% of the $366.89M in total assets.

    Cash and Equivalents$33.85M
    Total Debt$0
    Net Cash$33.85M
    Net Cash Per Share$0.31
    Working Capital$249.97M
    Shareholder Equity$339.50M
    Book Value Per Share$3.14
    Total Assets$366.89M
    Total Liabilities$27.38M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $692.00K of capital spending, operating cash flow left -$129.20M of free cash flow.

    Operating Cash Flow-$128.51M
    Capital Expenditures$692.00K
    Free Cash Flow-$129.20M
    FCF Per Share-$1.25
    Depreciation and Amortization$2.06M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Growth

    Book Value Per Share Growth (2Y CAGR)+5.96%
    Tangible Book Per Share Growth (2Y CAGR)+5.96%

    Revenue and profit by year

    Dividends and Yields

    ORIC does not pay a dividend. Its free cash flow yield is -14.93%.

    FCF Yield-14.93%
    Buyback Yield-7.15%
    Shareholder Yield-7.15%

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About ORIC

    What is ORIC's market cap?

    Oric Pharmaceuticals has a market cap of $779.47M. Its enterprise value, which adds debt and subtracts cash, is $745.62M.

    How many shares of ORIC are outstanding?

    Oric Pharmaceuticals has 108.18M shares outstanding. The count is up 9.32% from a year earlier.

    Does ORIC pay a dividend?

    No. Oric Pharmaceuticals does not pay a dividend.

    How much debt does ORIC have?

    Oric Pharmaceuticals has $0 of total debt and $33.85M of cash and equivalents, a net cash position of $33.85M.